website: 86th General Session & Exhibition of the IADR

ABSTRACT: 3325  

Anesthetic efficacy of ropivacaine with epinephrine in maxillary infiltration

M. FRANZ-MONTAN1, A.R. SILVA2, J. RANALI1, F.C. GROPPO1, E.D. PAULA3, and M.C. VOLPATO1, 1Universidade Estadual de Campinas- UNICAMP, Piracicaba, Brazil, 2Universidade Estadual de Campinas- UNICAMP, Brazil, 3State University of Campinas – Biological Institute, Brazil

Objectives: To evaluate the anesthetic efficacy of ropivacaine with epinephrine and the effects on the cardiovascular system after maxillary infiltration. Methods: In this blinded crossover study, forty healthy volunteers received, in different sessions, 1.8mL of 2% lidocaine with 1:100,000 epinephrine (Lido100) and 0.5% ropivacaine with 1:200,000 epinephrine (Ropi200) in the buccal fold of the maxillary right canine region. Anesthesia success, onset and duration of pulpal anesthesia were evaluated in the lateral incisor, canine, 1st and 2nd premolar with electric stimulation. Gingival and lip anesthesia was evaluated by pinprick test. Pain during anesthetic injection was recorded on a visual analogue scale (VAS). Arterial pressure and heart rate changes were monitored: before (1), during (2) right after (3) and 5-min after (4) local anesthesia. Results: The results (mean±SD) are shown in the table. No statistically significant differences (p>0.05) were observed between Lido100 and Ropi200, except for duration of gingival and lip anesthesia which were longer with the use of Ropi200. The cardiovascular parameters remained stable (p<0.05) and within the normal range.

Solution

Lateral

incisor

Canine

1st Premolar

2nd Premolar

Gingiva

Lip

Anesthesia success rate (%)

Lido100

55

95

85

67.5

100

100

Ropi200

15

75

70

62.5

100

100

Onset of anesthesia (min)

Lido100

4.2 (±0.9)

2.8 (±0.3)

2.5 (±0.2)

2.8 (±0.3)

0

0

Ropi200

4.6 (±0.7)

3.2 (±0.3)

3.3 (±0.3)

3.5 (±0.6)

0

0

Duration of anesthesia (min)

Lido100

26.7 (±6.7)

36.9 (±5.9)

39.6 (±5.5)

31.5 (±4.7)

134.8 (±8.8)

198.4 (±9.2)

Ropi200

4.6 (±0.7)

43.4 (±6.8)

45.8 (±6.2)

34.5 (±4.6)

272.5 (±18.4) *

407.7 (±18.8) *

VAS

Lido100

28.9 (±3.3)

Ropi200

30.8 (±3.9)

Conclusion: There is no advantage in the use of 0.5% ropivacaine with 1:200,000 epinephrine for maxillary infiltration, except in procedures in which post surgical pain from soft tissues is expected. Supported by FAPESP 2006/00121-9, 2006/53255-2.
Back to Top